Related Experiment Video
Updated: Jan 9, 2026

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Nicotine and cannabis vaping among U.S. emerging young adults: Findings from 2022 and 2023 National Survey on Drug
Nayoung Kim1, Joy Haizelden1, Gracie Avery1
1University of Alabama, College of Human Environmental Science, Department of Health Science, Tuscaloosa, AL, USA.
Objectives:
With recent rise in nicotine and cannabis vaping and growing evidence of their negative health effects, especially when co-vaped, understanding vaping patterns is important. This study examined national prevalence and factors associated with nicotine and cannabis vaping among U.S. emerging young adults.
Methods:
Cross-sectional data from the 2022 and 2023 National Survey on Drug Use and Health were used to assess past-month rates of exclusive nicotine vaping, exclusive cannabis vaping, and co-vaping (versus no vaping) and examine its associations with sociodemographic characteristics, mental health, other substance use (e.g., tobacco, alcohol, binge drinking), substance use disorders (nicotine dependence, alcohol use disorder), and cannabis legalization.
Results:
Among emerging adults, 16.0% reported exclusive nicotine vaping, 4.3% exclusive cannabis vaping, and 8.1% co-vaping in the past month. Non-Hispanic White individuals, those with lower education, and those identified as sexual minorities reported higher rates of vaping. Severe psychological distress, tobacco and alcohol co-use, and alcohol use disorder increased odds of all vaping behaviors. Medical cannabis legalization significantly increased odds of exclusive cannabis vaping and co-vaping, but not exclusive nicotine vaping.
Conclusions:
Vaping patterns vary by certain sociodemographic characteristics and cannabis policy. Mental health challenges and substances co-use consistently elevated risks of all forms of vaping among this vulnerable population.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Emerging Adulthood

